Epstein Secrets

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

ansitional parliament has approved the step," according to "two Sudanese government sources." Reuters says "the comments are the clearest sign that Hamdok, under pressure from the United States, is willing to contemplate Sudan establishing ties with former adversary Israel." However, "such a move would

63> (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health." The drug

ansitional parliament has approved the step," according to "two Sudanese government sources." Reuters says "the comments are the clearest sign that Hamdok, under pressure from the United States, is willing to contemplate Sudan establishing ties with former adversary Israel." However, "such a move would

e AP (10/22, Marchione) reports that the "antiviral medicine given to hospitalized patients through an IV," being marketed by manufacturer Gilead as Veklury, "cut the time to recovery by five days - from 15 days to 10 on average - in a large study led by the U.S. National Institutes of Health." The drug

ansitional parliament has approved the step," according to "two Sudanese government sources." Reuters says "the comments are the clearest sign that Hamdok, under pressure from the United States, is willing to contemplate Sudan establishing ties with former adversary Israel." However, "such a move woul